Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease
Objective: To determine the association between baseline modifiable comorbidities, including cardiovascular disease risk factors, mood disorders, and sleep characteristics, and the rate of change in…Task based profiles of language impairment in Parkinson’s Disease
Objective: This study aimed to add to our understanding of language impairment in people with Parkinson's Disease (PwPD). Background: Language difficulties are increasingly reported in…Anticholinergic Use in Parkinson’s Disease: Practice Patterns in Patients with Cognitive Impairment
Objective: To explore utilization of anticholinergic medications using the Parkinson Foundation Quality Improvement Initiative (PF-QII) registry. Background: Recent publications have highlighted the association between anticholinergic…Clinical and genetic profile of Familial Parkinson´s disease in Cali – Colombia
Objective: This study aims to describe the genetic and clinical profile of 32 subjects with familial PD using NGS genetic panel and eMotion software system…Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study
Objective: In this follow-up study, we aimed to explore the temporal changes in brain acetylcholinesterase activity and cognitive function of iRBD patients. Background: Isolated REM…Enhancement of executive functions but not memory by multidomain cognitive group training in Parkinson patients with mild cognitive impairment: A multicenter randomized controlled trial
Objective: To determine cognitive training (CT) effects in Parkinson’s disease (PD) patients with mild cognitive impairment (PD-MCI) on cognitive and non-cognitive outcomes compared to an…Performance at the Category-Exemplars language test (CATEX) in Parkinson’s disease and Huntington’s disease Italian population
Objective: This study aims to explore CATEX sensitivity to detect early cognitive deficits in Huntington’s disease (HD) and Parkinson’s disease (PD) Italian population. Background: PD…Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition
Objective: To examine the impact of Lewy body disease neuropathology (LBD) on domain-specific cognitive impairment in isolation and in combination with Alzheimer’s disease neuropathologic change…Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials
Objective: This study aimed to evaluate the effects of rTMS for improving cognition of PD patients. Background: Up to 20%–50% of patients with Parkinson’s disease…Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients
Objective: The study aimed to investigate apathy subdomains (reward deficiency syndrome, emotional distress, executive function, auto-activation deficit) and cognitive executive functions differences between PD patients…
- « Previous Page
- 1
- …
- 50
- 51
- 52
- 53
- 54
- …
- 117
- Next Page »